160 related articles for article (PubMed ID: 26851523)
1. Sialic acid-specific affinity chromatography for the separation of erythropoietin glycoforms using serotonin as a ligand.
Meininger M; Stepath M; Hennig R; Cajic S; Rapp E; Rotering H; Wolff MW; Reichl U
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():193-203. PubMed ID: 26851523
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive glycan analysis of twelve recombinant human erythropoietin preparations from manufacturers in China and Japan.
Cowper B; Li X; Yu L; Zhou Y; Fan WH; Rao CM
J Pharm Biomed Anal; 2018 May; 153():214-220. PubMed ID: 29502007
[TBL] [Abstract][Full Text] [Related]
3. Measurement of sialic acid content is insufficient to assess bioactivity of recombinant human erythropoietin.
Yanagihara S; Taniguchi Y; Hosono M; Yoshioka E; Ishikawa R; Shimada Y; Kadoya T; Kutsukake K
Biol Pharm Bull; 2010; 33(9):1596-9. PubMed ID: 20823580
[TBL] [Abstract][Full Text] [Related]
4. Affinity chromatography based on a combinatorial strategy for rerythropoietin purification.
Martínez-Ceron MC; Marani MM; Taulés M; Etcheverrigaray M; Albericio F; Cascone O; Camperi SA
ACS Comb Sci; 2011 May; 13(3):251-8. PubMed ID: 21495625
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic separation of recombinant human erythropoietin isoforms.
Gokana A; Winchenne JJ; Ben-Ghanem A; Ahaded A; Cartron JP; Lambin P
J Chromatogr A; 1997 Dec; 791(1-2):109-18. PubMed ID: 9463897
[TBL] [Abstract][Full Text] [Related]
6. Purification of human erythropoietin by affinity chromatography using cyclic peptide ligands.
Kish WS; Roach MK; Sachi H; Naik AD; Menegatti S; Carbonell RG
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():1-12. PubMed ID: 29625371
[TBL] [Abstract][Full Text] [Related]
7. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
8. Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures.
Yuen CT; Storring PL; Tiplady RJ; Izquierdo M; Wait R; Gee CK; Gerson P; Lloyd P; Cremata JA
Adv Exp Med Biol; 2005; 564():141-2. PubMed ID: 16400821
[No Abstract] [Full Text] [Related]
9. Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant.
Kim HJ; Lee SJ; Kim HJ
J Pharm Biomed Anal; 2008 Nov; 48(3):716-21. PubMed ID: 18722069
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells.
Lee CG; Oh MJ; Park SY; An HJ; Kim JH
Sci Rep; 2018 May; 8(1):7273. PubMed ID: 29740059
[TBL] [Abstract][Full Text] [Related]
11. Expression of functionally active sialylated human erythropoietin in plants.
Jez J; Castilho A; Grass J; Vorauer-Uhl K; Sterovsky T; Altmann F; Steinkellner H
Biotechnol J; 2013 Mar; 8(3):371-82. PubMed ID: 23325672
[TBL] [Abstract][Full Text] [Related]
12. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes.
Son YD; Jeong YT; Park SY; Kim JH
Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238
[TBL] [Abstract][Full Text] [Related]
13. Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk.
Montesino R; Toledo JR; Sánchez O; Sánchez A; Harvey DJ; Royle L; Dwek RA; Rudd PM; Gerwig GJ; Kamerling JP; Cremata JA
Arch Biochem Biophys; 2008 Feb; 470(2):163-75. PubMed ID: 18083109
[TBL] [Abstract][Full Text] [Related]
14. Capillary electrophoretic separation of human recombinant erythropoietin (r-HuEPO) glycoforms.
Watson E; Yao F
Anal Biochem; 1993 May; 210(2):389-93. PubMed ID: 8512075
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry.
Gong B; Burnina I; Stadheim TA; Li H
J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and assessment of a de novo affinity adsorbent for the purification of recombinant human erythropoietin.
El Khoury G; Wang Y; Wang D; Jacob SI; Lowe CR
Biotechnol Bioeng; 2013 Nov; 110(11):3063-9. PubMed ID: 23613257
[TBL] [Abstract][Full Text] [Related]
17. A single monoclonal antibody as probe to detect the entire set of native and partially unfolded rhEPO glycoforms.
Amadeo I; Oggero M; Zenclussen ML; Robles L; Pereira D; Kratje R; Etcheverrigaray M
J Immunol Methods; 2004 Oct; 293(1-2):191-205. PubMed ID: 15541288
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions.
Darling RJ; Kuchibhotla U; Glaesner W; Micanovic R; Witcher DR; Beals JM
Biochemistry; 2002 Dec; 41(49):14524-31. PubMed ID: 12463751
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the sialylation of recombinant EPO produced in CHO cells via the inhibition of glycosphingolipid biosynthesis.
Kwak CY; Park SY; Lee CG; Okino N; Ito M; Kim JH
Sci Rep; 2017 Oct; 7(1):13059. PubMed ID: 29026192
[TBL] [Abstract][Full Text] [Related]
20. Soluble expression and partial purification of recombinant human erythropoietin from E. coli.
Jeong TH; Son YJ; Ryu HB; Koo BK; Jeong SM; Hoang P; Do BH; Song JA; Chong SH; Robinson RC; Choe H
Protein Expr Purif; 2014 Mar; 95():211-8. PubMed ID: 24412408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
